Balolong, Maria Sophia S.
HRN: 27-96-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/17/2025
10/24/2025
IV
200mg
Q 6H
Partial Thickness Burns, Face, Left Side Of Torso, Thigh
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes